ReviewJournal of hematology & oncology2017
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy.
Erhao Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
66 papers cite itlatest 60 shown
this paperpooled itcites it